The regulation of vascular function by P2 receptors: multiple sites and multiple receptors.

[1]  C. Yang,et al.  Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells. , 1996, Molecular pharmacology.

[2]  J. T. Turner,et al.  The P2 Nucleotide Receptors , 1998, The Receptors.

[3]  Marc Parmentier,et al.  Cloning of a Human Purinergic P2Y Receptor Coupled to Phospholipase C and Adenylyl Cyclase* , 1997, The Journal of Biological Chemistry.

[4]  J. Cazenave,et al.  Presence of P2X1 Purinoceptors in Human Platelets and Megakaryoblastic Cell Lines , 1997, Thrombosis and Haemostasis.

[5]  B. Berk,et al.  Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. , 1997, Circulation research.

[6]  J. Cazenave,et al.  The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells , 1997, FEBS letters.

[7]  G. Wilkinson,et al.  P2 purinoceptor-stimulated conversion of arginine to citrulline in bovine endothelial cells is reduced by inhibition of protein kinase C. , 1996, Biochemical pharmacology.

[8]  N. Wilkie,et al.  Stimulated Mitogen-activated Protein Kinase Is Necessary but Not Sufficient for the Mitogenic Response to Angiotensin II , 1996, The Journal of Biological Chemistry.

[9]  J. T. Turner,et al.  Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS‐insensitive response to UTP , 1996, British journal of pharmacology.

[10]  D. Mills,et al.  ADP Receptors on Platelets , 1996, Thrombosis and Haemostasis.

[11]  K. Starke,et al.  P2-purinoceptors on postganglionic sympathetic neurones. , 1996, Journal of autonomic pharmacology.

[12]  G. Burnstock.  Development and perspectives of the purinoceptor concept. , 1996, Journal of autonomic pharmacology.

[13]  J. Neary,et al.  The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase , 1996, British journal of pharmacology.

[14]  H. Schlüter,et al.  Vascular actions of diadenosine phosphates. , 1996, Journal of autonomic pharmacology.

[15]  N. Wilkie,et al.  Phosphorylation and activation of p42 and p44 mitogen-activated protein kinase are required for the P2 purinoceptor stimulation of endothelial prostacyclin production. , 1996, The Biochemical journal.

[16]  B. Cronstein,et al.  Purinergic mechanisms in inflammation , 1996 .

[17]  D. Ferrari,et al.  Purines and cell death , 1996 .

[18]  D. Strøbæk,et al.  P2‐purinoceptor‐mediated formation of inositol phosphates and intracellular Ca2+ transients in human coronary artery smooth muscle cells , 1996, British journal of pharmacology.

[19]  G. Burnstock,et al.  Evidence for a P2‐purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat , 1996, British journal of pharmacology.

[20]  J. Nishimura,et al.  Dual regulation of cerebrovascular tone by UTP: P2U receptor‐mediated contraction and endothelium‐dependent relaxation , 1996, British journal of pharmacology.

[21]  J. Nishimura,et al.  P2UPurinergic Activation Leads to the Cell Cycle Progression from the G1to the S and M Phases but Not from the G0to G1Phase in Vascular Smooth Muscle Cells in Primary Culture , 1996 .

[22]  G. Burnstock,et al.  Discrimination by PPADS between endothelial P2Y‐ and P2U‐ purinoceptors in the rat isolated mesenteric arterial bed , 1996, British journal of pharmacology.

[23]  C. Brown,et al.  Protein kinase C isoforms in bovine aortic endothelial cells: role in regulation of P2Y‐ and P2U‐purinoceptor‐stimulated prostacyclin release , 1996, British journal of pharmacology.

[24]  A. Mackenzie,et al.  Activation of Receptor-operated Cation Channels via P Not P Purinoceptors in Human Platelets (*) , 1996, The Journal of Biological Chemistry.

[25]  P. Insel,et al.  P Purinergic Receptor Agonists Enhance cAMP Production in Madin-Darby Canine Kidney Epithelial Cells via an Autocrine/Paracrine Mechanism (*) , 1996, The Journal of Biological Chemistry.

[26]  C. Schalkwijk,et al.  Maximal epidermal growth-factor-induced cytosolic phospholipase A2 activation in vivo requires phosphorylation followed by an increased intracellular calcium concentration. , 1996, The Biochemical journal.

[27]  William L. Smith,et al.  Calcium-mediated Translocation of Cytosolic Phospholipase A2 to the Nuclear Envelope and Endoplasmic Reticulum (*) , 1995, The Journal of Biological Chemistry.

[28]  B. Nürnberg,et al.  The human platelet ADP receptor activates Gi2 proteins. , 1995, The Biochemical journal.

[29]  Y. Takuwa,et al.  Molecular Cloning and Functional Analysis of a Novel P2 Nucleotide Receptor (*) , 1995, The Journal of Biological Chemistry.

[30]  T. Nishizaki,et al.  ATP activates the potassium channel and enhances cytosolic Ca2+ release via a P2Y purinoceptor linked to pertussis toxin-insensitive G-protein in brain artery endothelial cells. , 1995, Biochemical and biophysical research communications.

[31]  W. Watt,et al.  Pharmacological selectivity of the cloned human P2U‐purinoceptor: potent activation by diadenosine tetraphosphate , 1995, British journal of pharmacology.

[32]  H. Bourne.  Team blue sees red , 1995, Nature.

[33]  M. J. Robertson,et al.  A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. , 1995, Trends in pharmacological sciences.

[34]  K. Hirata,et al.  Inhibition of endothelial nitric oxide synthase activity by protein kinase C. , 1995, Hypertension.

[35]  G. Burnstock,et al.  Uptake and Flow-induced Release of Uridine Nucleotides from Isolated Vascular Endothelial Cells , 1995 .

[36]  R. Evans,et al.  Characterization of P2‐purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses , 1994, British journal of pharmacology.

[37]  G. Wilkinson,et al.  Differential regulation of inositol 1,4,5‐trisphosphate by co‐existing P2Y‐purinoceptors and nucleotide receptors on bovine aortic endothelial cells , 1994, British journal of pharmacology.

[38]  G. Wilkinson,et al.  P2Y purinoceptor and nucleotide receptor-induced relaxation of precontracted bovine aortic collateral artery rings: differential sensitivity to suramin and indomethacin. , 1994, The Journal of pharmacology and experimental therapeutics.

[39]  H. Schlüter,et al.  Diadenosine phosphates and the physiological control of blood pressure , 1994, Nature.

[40]  K. Starke,et al.  Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter release , 1993, Neuroscience.

[41]  P. Vigne,et al.  ADP induces inositol phosphate-independent intracellular Ca2+ mobilization in brain capillary endothelial cells. , 1993, The Journal of biological chemistry.

[42]  G. Wilkinson,et al.  Evidence for a nucleotide receptor on adrenal medullary endothelial cells linked to phospholipase C and phospholipase D , 1993, British journal of pharmacology.

[43]  S. Pirotton,et al.  Heterogeneity of ATP receptors in aortic endothelial cells. Involvement of P2y and P2u receptors in inositol phosphate response. , 1993, Circulation research.

[44]  F. Orallo,et al.  Effects of ATP on cultured smooth muscle cells from rat aorta , 1993, British journal of pharmacology.

[45]  G. Wilkinson,et al.  The regulation of aortic endothelial cells by purines and pyrimidines involves co‐existing P2y‐purinoceptors and nucleotide receptors linked to phospholipase C , 1993, British journal of pharmacology.

[46]  K. Schrör.  The basic pharmacology of ticlopidine and clopidogrel. , 1993, Platelets.

[47]  L. Heppel,et al.  Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells , 1992, Journal of cellular physiology.

[48]  A. van Coevorden,et al.  Effects of adenine nucleotides on the proliferation of aortic endothelial cells. , 1992, Circulation research.

[49]  K. Shinozuka,et al.  Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta. , 1990, The Journal of pharmacology and experimental therapeutics.

[50]  J. Pearson,et al.  Regulation of P2y‐purinoceptor‐mediated prostacyclin release from human endothelial cells by cytoplasmic calcium concentration , 1988, British journal of pharmacology.

[51]  G. Loizou,et al.  Pharmacological effects of L-AMP-PCP on ATP receptors in smooth muscle. , 1986, European journal of pharmacology.

[52]  Nicolas Meeùs,et al.  Léon J-P. , 1986 .

[53]  M. da Prada,et al.  Adenine-, guanine- and uridine-5'-phosphonucleotides in blood platelets and storage organelles of various species. , 1971, The Journal of pharmacology and experimental therapeutics.